R&D spending by large pharmaceutical companies is stabilizing despite continued restructuring. However, as pharmaceutical companies continue to streamline R&D, resources are shifting to clinical trials. Forced to balance between cost containment and drug development to secure future revenues, companies are prioritizing investments in drugs with the strongest growth potential, especially for therapies that will both […]
As IBO detailed in the July 15 issue, analytical instrument and lab product firms are pursuing more direct sales opportunities in developing markets through new subsidiaries and offices. Five firms `recently announced similar expansions. In September, Life Technologies celebrated the opening of a Customer Experience Center in Moscow, Russia—its first demonstration laboratory facility in the […]
This month, AVIA Biosystems introduced its first product, the Model 2304 Automated Protein Denaturation System. Designed to determine protein stability, it automates chemical denaturation measurements. A complement to physical denaturation studies of protein stability, chemical denaturalization enables the measurement of thermodynamic values at a given temperature without the need to extrapolate from a higher temperature, […]
In the era of productivity pressure, paperless labs and drug development partnerships, standards are becoming a greater issue for laboratory-generated data. Data standardization facilitates the transfer, analysis and storage of data by creating a common language that can be universally read and written. Standards can be applied to many aspects of data, including format and […]
Enthusiasm has dampened for instrument and lab product sales growth in coming months, according to the annual fall IBO Business Climate Survey. Following a rebound in optimism this spring (see IBO 5/15/13), respondents are again moderating their expectations for sales growth over the next six months. More moderate expectations are also evident in the International […]
For the second quarter, revenues for IBO’s Laboratory Equipment/Consumables Sales Index grew 1.2%, 2.2% excluding currency, to $4,111 million. Operating profits for the Index rose 0.2% to $738 million. Based on continuing operations, operating margin slipped 30 basis points to 17.9% of sales. For the fiscal second quarter ending May 31, revenue for Gerresheimer’s Life […]
Economic reforms in Japan have put science and technology at center stage. Under Prime Minister Shinzo Abe, who was elected last year, the country has embarked on a new economic policy termed “abenomics” that is designed to spur growth via government stimulus, monetary infusion through new central banking policies and structural changes. The plan aims […]
Bruker has announced the world’s first Magnetic Particle Imaging (MPI) scanner. The scanner is intended to be a new complementary technology for preclinical imaging of small animals. It is codeveloped and comarketed with Royal Philips, manufactured by Bruker and will ship this year. The key enabling technology of MPI is a tracer that produces a […]
Despite concerns over the US debt ceiling and a potential government shutdown, equity markets advanced in September due to the Federal Reserve’s decision to continue its bond purchase program, as well as improving economic data, including higher personal income and spending. However, consumer sentiment shifted more negatively in September as a result of discouraging prospects […]
The second of IBO’s biannual new laboratory roundup focuses on new academic, pharmaceutical, and oil and gas labs. In addition, the table on page 3 highlights plans for new labs for the automotive and food industries, as well as for cancer research. Seven life science teaching labs have recently been announced. Johns Hopkins’ Undergraduate Teaching […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
